Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Oral and Maxillofacial Surgery|August 1, 1997
Heterotopic salivary gland adenocarcinoma in the cervical regionT Hata, H Iga, S Imai, et al.
Cancer Research|December 15, 1990
Effect of hexamethylene bisacetamide and cyclosporin A on recovery of herpes simplex virus type 2 from the in vitro model of latency in a human neuroblastoma cell lineY Kondo, Y Yura, H Iga, et al.
Archives of Virology|January 1, 1986
A latent infection of herpes simplex virus type 2 in a human neuroblastoma cell line IMR-32Y Yura, K Terashima, H Iga, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|February 1, 1991
Herpes simplex virus type 1 and type 2 infection in human oral mucosa in cultureY Yura, H Iga, Y Kondo, et al.
Archives of Virology|January 1, 1987
The role of epithelial cell differentiation in the expression of herpes simplex virus type 1 in normal human oral mucosa in cultureY Yura, H Iga, K Terashima, et al.
The Journal of Investigative Dermatology|April 1, 1992
Heparan sulfate as a mediator of herpes simplex virus binding to basement membraneY Yura, H Iga, Y Kondo, et al.
Cancer Research|December 1, 1989
Expression of neurofilaments in a neoplastic human salivary intercalated duct cell line or its derivatives and effect of nerve growth factor on the cellular proliferation and phenotypeH Iga, M Azuma, S Nagamine, et al.
Journal of the National Cancer Institute|February 6, 1991
Enhanced replication of herpes simplex virus by hexamethylene bisacetamideY Yura, Y Kondo, H Iga, et al.
International Journal of Oral and Maxillofacial Surgery|August 1, 1986
Recurrent intraoral herpes simplex virus infectionY Yura, H Iga, K Terashima, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 1, 1997
Induction of tumour differentiation and apoptosis and LeY antigen expression in treatment with differentiation-inducing agent, vesnarinone, of a patient with salivary adenoid cystic carcinomaM Sato, K Harada, Y Yura, et al.
Pageof 2